BioSpace News Archive

Career Advice

8 Warning Signs You Need a New Job Immediately

Do you know about the signs you need a new job? If not then you should be aware of them as they can help you get out of a boring job and get a new inspiring job.

June 28, 2018
·
4 min read
Genetown

Platelet BioGenesis Receives $3.5 Million Grant from Department of Defense

Platelet Biogenesis (PBG) was awarded a two-year, $3.5 million grant from the U.S. Department of Defense (DoD). The funds are to support the company’s proprietary bioreactor to produce therapeutic amounts of platelets.

June 28, 2018
·
2 min read
·
Mark Terry
FDA

Array Snags FDA Approval for BRAF-Mutant Metastatic Melanoma Combination Treatment

Array BioPharma, Inc. secured approval for its combination treatment for BRAF-mutant metastatic melanoma.

June 28, 2018
·
2 min read
·
Alex Keown
Drug Development

Lilly’s Taltz Hit Primary and Secondary Endpoints in Ankylosing Spondylitis Trial

Eli Lilly and Company announced the results of its COAST-W Phase III clinical trial of Taltz (ixekizumab) to treat Ankylosing Spondylitis (AS). The trial met both primary and major secondary endpoints.

June 28, 2018
·
2 min read
·
Mark Terry
FDA

Sprout Relaunches Female Sex Drive Pill Addyi at Half the Price Charged Under Valeant

After failing to gain market share under the umbrella of Valeant Pharmaceuticals, Addyi is getting a relaunch at half the price.

June 28, 2018
·
2 min read
·
Alex Keown
How to Be Your Own Boss, Even When You Work for Someone Else

You don’t have to own your own company to “be your own boss.” You can enjoy the benefits of an entrepreneurial mindset right now, right where you are, even if you work for someone else.

June 28, 2018
·
4 min read
Drug Development

Akebia and Keryx Merge to Become Leader in Therapies for Chronic Kidney Disease

Shares of Akebia Therapeutics are up more than 10 percent in premarket trading after the company announced it struck a merger agreement with Keryx Biopharmaceuticals, Inc. to create a company expected to be a leader in the development of renal disease therapies.

June 28, 2018
·
2 min read
·
Alex Keown
Deals

Takeda Shareholders Group Opposed to Shire Merger Lose Bid

A group of Takeda Pharmaceutical shareholders’ bid to halt the acquisition of Dublin-based Shire failed to gain traction.

June 28, 2018
·
2 min read
·
Mark Terry
June 29 Research Roundup: Oral Insulin, Poliovirus for Brain Tumors and More

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

June 28, 2018
·
4 min read
·
Mark Terry
Drug Development

BrainStorm Expands Leadership Team on Heels of Right-to-Try Controversy

The senior leadership team at Israel-based BrainStorm Cell Therapeutics, Inc. has changed with the appointments of two seasoned industry veterans Joseph Petroziello and Susan Ward.

June 28, 2018
·
2 min read
·
Alex Keown